Comparison of HIV Viral Suppression Outcome between Peer Support Group and Non- Peer Support Group in Chaiwan Hospital, Udonthani
DOI:
https://doi.org/10.14456/taj.2019.4Keywords:
HIV, intervention, Antiretroviral therapy, viral suppression, peer supportAbstract
Background and objective: Peer support intervention has been recommended as an adjunct to antiretroviral therapy, but the evaluation of this intervention was limited in Thailand. The aim of this study was to compare viral suppression rate between Peer Support Group (PSG) and non-PSG.
Methods: A retrospective cohort study of adults receiving ART between July 2013 and June 2018 in Chaiwan Hospital was performed. Viral suppression were compared by intention to treat between 2 groups, using Log-binomial regression for multivariable analysis to calculate adjusted odds ratios.
Results: There were 33 patients in PSG and 20 in non-PSG. The loss to follow-up rate was 3.0 % in PSG versus 15.0% in non-PSG. After 5 years, viral suppression between PSG and non-PSG was not a statistically significant difference. (adjusted OR, 2.73 ; 95% confidence interval , 0.42 to 18.01)
Conclusions: The difference in viral load suppression over five years between PSG and non-PSG did not reach statistical significance due to a small number of subjects. Further scale-up of study in Thailand should be considered.
Downloads
References
World Health Organization and UNAIDS [Internet]. Geneva: Q&A on HIV/AIDS estimates ; 2017 [cited 2019 Mar14]. Available from: http://www.unaids.org/en/regionscountries/countries/thailand
กรมควบคุมโรค กระทรวงสาธารณสุข. แนวทางการตรวจรักษาและป้องกันการติดเชื้อเอชไอวี ประเทศ ไทย ปี 2553. กรุงเทพมหานคร: ชุมนุมสหกรณ์การเกษตรแห่งประเทศไทยจำกัด; 2553.
กรมควบคุมโรค กระทรวงสาธารณสุข. แนวทางการตรวจรักษาและป้องกันการติดเชื้อเอชไอวี ประเทศ ไทย ปี 2557. กรุงเทพมหานคร: ชุมนุมสหกรณ์การเกษตรแห่งประเทศไทยจำกัด; 2557.
ข่าวสารเพื่อสื่อมวลชน [Internet] กรมควบคุมโรค กระทรวงสาธารณสุข. สธ.รณรงค์วันเอดส์โลกประจำปี 2561 เน้น “ตรวจเร็ว รักษาเร็ว ยุติเอดส์”; [เข้าถึงเมื่อวันที่ 14 มีนาคม 2562]. เข้าถึงได้จาก: https://ddc.moph.go.th/th/site/newsview/view/1861
The Joint United Nations Programme on HIV/AIDS (UNAIDS). The Gap Report Geneva, Switzerland: UNAIDS; 2014. [cited 2019 Mar14]. Available from: http://files.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf.
World Health Organization [Internet]. Geneva: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection; 2015 [cited 2019 Mar14]. Available from: https://www.who.int/hiv/pub/arv/arv2015-service-delivery-factsheet/en/
Mead S, Hilton D, Curtis L. Peer Support: A theoretical perspective. Psychiatric Rehabilitation Journal. 2001;25(2):134-41.
Kanters S, Park JJ, Chan K, et al. Use of peers to improve adherence to antiretroviral therapy: a global network meta-analysis. J Int AIDS Soc 2016; 19(1): 21141.
McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: A systematic review. Bull World Health Organ. 2013; 91(5): 377–85.
Delaugerre C, Ghosn J, Lacombe JM. Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access. Clin Infect Dis. 2015; 60: 463–472.
O’Connor J., et al., Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study. Lancet HIV, 2017. 4(7): p.e295–e302.
Aldir I, Horta A, Serrado M. Single-tablet regimens in HIV: does it really make a difference? Curr Med Res Opin 2014; 30: 89–97.
Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE et al. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 2014; 58(9): 1297-1307.
Chang LW, Kagaayi J, Nakigozi G, et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a clusterrandomized trial. PLoS One 2010; 5: e10923.
Taiwo BO, Idoko JA, Welty LJ, et al. Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting. J Acquir Immune Defic Syndr 2010; 54: 85–92.
